Clinical and Molecular Hepatology (Dec 2016)
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Abstract
No abstracts available.Keywords
Clinical and Molecular Hepatology (Dec 2016)